Abstract:See Josephs (doi:10.1093/brain/awx367) for a scientific commentary on this article.In many neurodegenerative disorders, familial forms have provided important insights into the pathogenesis of their corresponding sporadic forms. The first mutations associated with frontotemporal lobar degeneration (FTLD) were found in the microtubule-associated protein tau (MAPT) gene on chromosome 17 in families with frontotemporal degeneration and parkinsonism (FTDP-17). However, it was soon discovered that 50% of these families had a nearby mutation in progranulin. Regardless, the original FTDP-17 nomenclature has been retained for patients with MAPT mutations, with such patients currently classified independently from the different sporadic forms of FTLD with tau-immunoreactive inclusions (FTLD-tau). The separate classification of familial FTLD with MAPT mutations implies that familial forms cannot inform on the pathogenesis of the different sporadic forms of FTLD-tau. To test this assumption, this study pathologically assessed all FTLD-tau cases with a known MAPT mutation held by the Sydney and Cambridge Brain Banks, and compared them to four cases of four subtypes of sporadic FTLD-tau, in addition to published case reports. Ten FTLD-tau cases with a MAPT mutation (K257T, S305S, P301L, IVS10+16, R406W) were screened for the core differentiating neuropathological features used to diagnose the different sporadic FTLD-tau subtypes to determine whether the categorical separation of MAPT mutations from sporadic FTLD-tau is valid. Compared with sporadic cases, FTLD-tau cases with MAPT mutations had similar mean disease duration but were younger at age of symptom onset (55 ± 4 years versus 70 ± 6 years). Interestingly, FTLD-tau cases with MAPT mutations had similar patterns and severity of neuropathological features to sporadic FTLD-tau subtypes and could be classified into: Pick's disease (K257T), corticobasal degeneration (S305S, IVS10‰+‰16, R406W), progressive supranuclear palsy (S305S) or globular glial tauopathy (P301L, IVS10‰+‰16). The finding that the S305S mutation could be classified into two tauopathies suggests additional modifying factors. Assessment of our cases and previous reports suggests that distinct MAPT mutations result in particular FTLD-tau subtypes, supporting the concept that they are likely to inform on the varied cellular mechanisms involved in distinctive forms of sporadic FTLD-tau. As such, FTLD-tau cases with MAPT mutations should be considered familial forms of FTLD-tau subtypes rather than a separate FTDP-17 category, and continued research on the effects of different mutations more focused on modelling their impact to produce the very different sporadic FTLD-tau pathologies in animal and cellular models.

Voluntary nystagmus masquerading as Tullio's Phenomenon.

Homotypic regulatory clusters in Drosophila.

Genetic Analysis of PICK1 Gene in Alzheimer's Disease: A Study for Finding a New Gene Target

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Phenotypically concordant distribution of pick bodies in aphasic versus behavioral dementias

Full Sequencing and Haplotype Analysis of MAPT in Parkinson's Disease and Rapid Eye Movement Sleep Behavior Disorder

Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia

A Comprehensive Resource for Induced Pluripotent Stem Cells from Patients with Primary Tauopathies

The MAPT p.E342K and p.R406W mutations are associated with progressive supranuclear palsy with atypical features

Meta-analysis of the association between variants in MAPT and neurodegenerative diseases.

Partition features and renaturation enhancement of chymosin in aqueous two-phase systems.

Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies

Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome Sequencing

Residual activity of denatured transforming DNA of Haemophilus influenzae: a natrually occurring cross-linked DNA.

MAPT haplotype-associated transcriptomic changes in progressive supranuclear palsy

A trade-off relationship between chest compression depth and chest wall recoil during cardiopulmonary resuscitation.

CYP1B1 - RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET

Association Between MAPT Haplotype and Memory Function in Patients with Parkinson's Disease and Healthy Aging Individuals.

Frontotemporal dementia and its subtypes: a genome-wide association study

Genome-wide association study and functional validation implicates JADE1 in tauopathy

Genome-wide Association Study Identifies MAPT Locus Influencing Human Plasma Tau Levels